Bio2 Medical has announced that the Angel catheter, a new device for the prevention of pulmonary embolism, was placed in two patients at St Mary’s Medical Center in West Palm Beach, USA, by Lawrence Lottenberg and Robert Borrego on 29 September. This is the first commercial usage of the device.
Profusa has announced that receiving the CE mark to market its Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen.
Ra Medical has announced receiving CE mark approval for the Dabra atherectomy system with catheter.
Medtronic has announced that the US FDA has cleared the TrailBlazer angled support catheter for use in the peripheral vascular system. Support catheters such as the Trailblazer are often used in endovascular procedures treating complex peripheral artery disease. FDA clearance was received on September 23, 2016.
Shockwave Medical has announced plans for DISRUPT PAD III—what is claims is the “largest ever” multicentre randomised study to exclusively enrol patients with calcified peripheral artery disease. Previous DISRUPT PAD studies utilised Lithoplasty as primary therapy, demonstrating safe, effective and consistent revascularisation of calcified lesions while maintaining future treatment options. To date, the potential benefit of combination therapy in these patients has not yet been evaluated. DISRUPT PAD III will study use of the Shockwave Medical Lithoplasty system in combination with drug-coated balloon therapy to assess short- and long-term outcomes compared to those achievable using traditional balloon angioplasty prior to drug-coated balloon in a calcified patient population.
Spectranetics has announced that the final 12-month results of the Stellarex drug-coated balloon ILLUMENATE pivotal trial have been presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference (29 October–2 November, Washington, DC, USA). The ILLUMENATE trial’s co-principal investigators are Sean Lyden of the Cleveland Clinic, Cleveland, USA, who presented the data, and Prakash Krishnan, Mount Sinai, New York, USA.
Spectranetics has submitted its pre-market approval application for the Stellarex drug-coated angioplasty balloon to the US Food and Drug Administration (FDA). Stellarex is designed to restore and maintain blood flow to the superficial femoral and popliteal arteries in patients with peripheral artery disease.
Med Alliance has announced first patient enrolment in the first-in-man study of the Selution novel sirolimus-coated balloon. Patients were enrolled at the Universitaets-Herzzentrum, Bad Krozingen, Germany, and the Franziskus Krankenhaus, Berlin, Germany.
Six-month interim analysis of the Legflow drug-eluting balloon for the treatment of femoropopliteal occlusions (LEG-DEB) registry indicates that “the use of a new generation paclitaxel drug-coated balloon… represents a safe and effective therapeutic strategy,” according to the study investigators. Writing in the Interventional Journal of Cardiology, they note, “In this registry, as expected for this complex patient subset, the Legflow drug-coated balloon appears to be slightly less successful when compared to the outstanding performance achieved by drug-coated balloons in claudicating patients.”
Deep vein thrombosis is a serious but preventable medical condition in which blood clots occur, usually in veins in the lower leg, thigh, pelvis, and sometimes arms. It is treatable, but it can cause illness, disability, and death. It is often underdiagnosed, so it is important to seek medical care if symptoms appear.
Daiichi Sankyo Europe GmbH (hereafter Daiichi Sankyo) has announced data from a new analysis of the phase 3 Hokusai-VTE study, which showed that a reduced dose of LIXIANA® (edoxaban, once-daily 30 mg) was as effective and well-tolerated in preventing recurrent VTE episodes as the standard 60 mg edoxaban treatment regimen, and safer than warfarin in preventing bleeding events in patients meeting the criteria for dose reduction.
"Pulse" is one of the most well-known medical terms. It is symbolic of medicine and widely familiar as a measure of our heartbeat.
The heart rate is one of our vital signs - it is the number of times a minute that our heart contracts or beats.
Normal blood pressure is vital to life: without the pressure that forces our blood to flow around the circulatory system, no oxygen or nutrients would be delivered through our arteries to the tissues and organs.
Due to an absence of standardised protocols, major amputation is being over utilised worldwide as a treatment for critical limb ischaemia, according to Mary Yost, president and senior analyst at The Sage Group LLC, who gave a presentation at the 2016 New Cardiovascular Horizons annual meeting (1–3 June, New Orleans, USA).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos